DELPRINO, Laura
 Distribuzione geografica
Continente #
NA - Nord America 1.158
EU - Europa 780
AS - Asia 409
Continente sconosciuto - Info sul continente non disponibili 10
AF - Africa 2
Totale 2.359
Nazione #
US - Stati Uniti d'America 1.152
CN - Cina 199
IE - Irlanda 140
SE - Svezia 125
SG - Singapore 87
FI - Finlandia 85
KR - Corea 84
DE - Germania 82
AT - Austria 75
UA - Ucraina 69
IT - Italia 61
FR - Francia 44
GB - Regno Unito 44
PL - Polonia 36
JP - Giappone 13
VN - Vietnam 12
BE - Belgio 11
EU - Europa 10
CA - Canada 5
UZ - Uzbekistan 5
IN - India 4
NL - Olanda 4
ES - Italia 2
HK - Hong Kong 2
IR - Iran 2
SN - Senegal 2
BY - Bielorussia 1
CH - Svizzera 1
LK - Sri Lanka 1
MX - Messico 1
Totale 2.359
Città #
Chandler 223
Beijing 159
Dublin 140
Ann Arbor 104
Jacksonville 92
Vienna 75
Singapore 64
Dearborn 60
Medford 48
Princeton 43
Warsaw 36
Wilmington 27
Villeurbanne 26
Boston 20
Ashburn 18
Nyköping 16
Fremont 14
Houston 14
Milan 13
Boardman 12
Woodbridge 12
Brussels 11
Falls Church 10
Santa Clara 10
Dong Ket 9
Munich 8
Guangzhou 7
New York 6
Norwalk 6
Verona 6
Hefei 5
Fairfield 4
Kunming 4
Jinan 3
Naaldwijk 3
Nanjing 3
Torino 3
Wuhan 3
Ardabil 2
Auburn Hills 2
Cambridge 2
Central 2
Düsseldorf 2
Ferrara 2
Hanover 2
Lachine 2
Leawood 2
Los Angeles 2
Napoli 2
Saronno 2
Toronto 2
Turin 2
Alessandria Della Rocca 1
Amsterdam 1
Aversa 1
Berlin 1
Bologna 1
Borgaro Torinese 1
Catanzaro 1
Changsha 1
Chicago 1
Chongqing 1
Civitella Di Romagna 1
Dalkeith 1
Fuzhou 1
Genoa 1
Grafing 1
Jupiter 1
Lappeenranta 1
Lequile 1
Madrid 1
Manchester 1
Monmouth Junction 1
Mountain View 1
Nanchang 1
Philadelphia 1
Pune 1
Quzhou 1
Rajagiriya 1
Raritan 1
Ravenna 1
Redmond 1
Rescaldina 1
Rolesville 1
Rosolini 1
San Mateo 1
Settimo Torinese 1
Shaoxing 1
Shenzhen 1
Taizhou 1
Tijuana 1
Vancouver 1
Washington 1
Totale 1.386
Nome #
Veicolazione del paclitaxel mediante anticorpi monoclonali, macromolecole, liposomi 90
A new 'blocked' immunotoxin 88
Comparison of blocked and non-blocked ricin-antibody immunotoxins against human gastric carcinoma and colorectal adenocarcinoma cell lines 85
N-oxide as a potential function in the design of enzyme inhibitors. Application to 2,3-epoxysqualene-sterol cyclases. 80
A new "solid phase" procedure to synthesize immunotoxins (antibody-ribosome inactivating protein conjugates). 77
Synthesis of squalenoid acetylenes and allenes, as inhibitors of squalene epoxidase. 76
The squalene-2,3-epoxide cyclase as a model for the development of new drugs. 75
An original approach to conjugate monoclonal antibody and cytotoxic proteins in heterogeneous phase 74
2,3,4,5-Tetrahydroxy-5-(4-hydroxyphenyl)valeric acid: a new cleavable monofunctional reagent for monoclonal antibody labeling. 72
A new approach in the synthesis of immunotoxins: ribosome inactivating protein noncovalently bound to monoclonal antibody. 71
Antitumour activity of a sterically blocked ricin immunotoxin on a human colorectal adenocarcinoma grafted subcutaneously in nude mice 71
Veicolazione ed attività antitumorale di derivati della 5-fluorouridina mediante anticorpi monoclonali 71
Nuovi leganti eterobifunzionali utilizzabili per coniugazioni proteina-proteina 70
A preliminary pharmacokinetic study of docetaxel, carboplatin and concurrent radiotherapy for regionally advanced squamous cell carcinoma of the head and neck 69
Antibody-toxin conjugate preparation: effects of the linker on activity and stability 67
Gemcitabine and oxaliplatin in patients with metastatic breast cancer resistant to or pretreated with both anthracyclines and taxanes - Clinical and pharmacokinetic data 67
Nuova immunotossina attiva contro il carcinoma gastrico 65
Nuova immunotossina ad attività antitumorale specifica 62
Targeting of toxins by a non-covalently bound monoclonal antibody 61
Toxin targeting by monoclonal antibody on tumor cells: pharmacokinetics and biodistributions evaluations 59
Direzionamento di citotossine con anticorpi monoclonali per la terapia del cancro 59
Heterobifunctional reagents: new thioimidate derivatives 59
Targeting of 5-florouracil and derivatives in the treatment of human colorectal adenocarcinomas. 58
A new class of linkers: open chain thioimidate derivatives 57
Confronto dell'attività antitumorale in vitro ed in vivo di sistemi di drug-targeting 54
Progettazione, sintesi e cinetica di leganti "cleavable" per la preparazione di sistemi proteici a rilascio controllato. 50
Heterobifunctional reagents: new thioimidate derivatives 48
Synthesis and biological activity of a squalenoid maleimide and other classes of squalene derivatives as irreversible inhibitors of 2,3-oxidosqualene cyclase. 48
Toxin-targeted design for anticancer therapy. I: Synthesis and biological evaluation of new thioimidate heterobifunctional reagents. 48
Toxin-targeted design for anticancer therapy. II: Preparation and biological comparison of different chemically linked gelonin-antibody conjugates. 47
The squalene 2,3-epoxide cyclase as a model for the development of new drugs 47
Pharmacokinetics of cisplatin in semi-closed hyperthermic peritoneal perfusion (HPP) for treatment of peritoneal carcinomatosis 46
Nuovi agenti eterobifunzionali nella progettazione e preparazione di immunotossine 46
Synthesis of a new class of heterobifunctional cross-linking reagents useful for protein conjugation 46
Pharmacokinetics of an antibody-ricin conjugate administered intraperitoneally to mice 42
Toxin-MAb immunoconjugates against human ovarian carcinoma: derivatization and conjugation studies 40
Pharmacokinetic evaluation of gemcitabine and 2',2'-difluorodeoxycytidine-5'-triphosphate after prolonged infusion in patients affected by different solid tumors 40
Studies on the immunogenicity of the ribosome inactivating protein alpha sarcin: prediction of antigenic sites 38
Synthesis of acetylenes and allenes, as inhibitors of squalene epoxidase. 38
Targeting of taxol and derivatives by monoclonal antibodies, macromolecules and liposomes 35
Targeting and delivery of taxol to human adenocarcinoma cell lines 35
Pharmacokinetic and biodistribution studies of an immunoconjugate directed against human colorectal adenocarcinoma cell line 31
Totale 2.462
Categoria #
all - tutte 7.860
article - articoli 0
book - libri 0
conference - conferenze 3.592
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.452


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020300 0 0 37 6 14 55 46 10 51 47 19 15
2020/2021239 32 11 8 15 26 12 23 7 28 16 36 25
2021/2022338 7 3 4 23 13 5 18 13 7 15 120 110
2022/2023560 65 51 6 74 46 144 44 35 61 3 27 4
2023/2024152 20 33 12 10 7 7 7 1 0 6 11 38
2024/202588 5 69 14 0 0 0 0 0 0 0 0 0
Totale 2.462